GenX, the PFAS Replacement, Causes Liver Tumors in Mice

GenX (HFPO-DA), the chemical industry's chosen replacement for PFOA, caused liver tumors and reduced survival in mice. The "safer" alternative isn't looking so safe.

What the Study Found

A 2026 study in Regul Toxicol Pharmacol gave mice GenX at various doses for up to 18 months. At the highest dose (5 mg/kg/day), male mice had reduced survival and significantly more liver tumors.

Even at lower doses, liver cells were enlarging (a condition called hepatocellular hypertrophy). This was the most sensitive response and appeared in both males and females at 9 and 18 months. At 18 months, this effect wasn't seen below 0.1 mg/kg/day.

Beyond the Liver

The damage wasn't limited to the liver. Male mice also showed effects in the adrenal glands (at 5 mg/kg/day) and testes (at 0.5 mg/kg/day and above). The reproductive system was hit at doses 10 times lower than what caused tumors.

Gene analysis confirmed GenX activates the same liver pathway (PPARα) that other PFAS compounds use to cause damage.

The Replacement Problem

GenX was introduced as the safe successor to PFOA. It's used in manufacturing fluoropolymers and has been found in drinking water near production facilities. Now a toxicity study shows it causes the same type of liver damage as the chemical it replaced.

What You Can Do

Don't trust "PFOA-free" labels. GenX may be lurking in its place. Filter your drinking water. Avoid nonstick cookware and fluoropolymer-coated products. Check out non-toxic home essentials for genuinely PFAS-free options.

Also see non-toxic kitchen essentials for safer alternatives.

Source: Thompson CM, et al. (2026). Regul Toxicol Pharmacol.